Gustaaf W. Van Imhoff

Groningen, GR, Netherlands

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 39 publications

R-CODOX-M/R-IVAC versus DA-EPOCH-R in patients with newly diagnosed Burkitt lymphoma (HOVON/SAKK): final results of a multicentre, phase 3, open-label, randomised trial.

R-CODOX-M/R-IVAC versus DA-EPOCH-R in patients with newly diagnosed Burkitt lymphoma (HOVON/SAKK): final results of a multicentre, phase 3, open-label, randomised trial.

Journal: The Lancet. Haematology
Published: August 02, 2023

Long-Term Cause-Specific Mortality in Hodgkin Lymphoma Patients.

Long-Term Cause-Specific Mortality in Hodgkin Lymphoma Patients.

Journal: Journal of the National Cancer Institute
Published: June 22, 2020

Treatment of patients with MYC rearrangement positive large B-cell lymphoma with R-CHOP plus lenalidomide: results of a multicenter HOVON phase II trial.

Treatment of patients with MYC rearrangement positive large B-cell lymphoma with R-CHOP plus lenalidomide: results of a multicenter HOVON phase II trial.

Journal: Haematologica
Published: December 19, 2019

Alemtuzumab plus CHOP versus CHOP in elderly patients with peripheral T-cell lymphoma: the DSHNHL2006-1B/ACT-2 trial.

Alemtuzumab plus CHOP versus CHOP in elderly patients with peripheral T-cell lymphoma: the DSHNHL2006-1B/ACT-2 trial.

Journal: Leukemia
Published: December 14, 2019

Interim thymus and activation regulated chemokine versus interim 18 F-fluorodeoxyglucose positron-emission tomography in classical Hodgkin lymphoma response evaluation.

Interim thymus and activation regulated chemokine versus interim 18 F-fluorodeoxyglucose positron-emission tomography in classical Hodgkin lymphoma response evaluation.

Journal: British journal of haematology
Published: October 05, 2019

Risk factors associated with the development of moderate to severe chronic graft-versus-host disease after non-myeloablative conditioning allogeneic stem cell transplantation in patients with AML or MDS.

Risk factors associated with the development of moderate to severe chronic graft-versus-host disease after non-myeloablative conditioning allogeneic stem cell transplantation in patients with AML or MDS.

Journal: Human cell
Published: September 06, 2019

Rituximab-PECC induction followed by 90 Y-ibritumomab tiuxetan consolidation in relapsed or refractory DLBCL patients who are ineligible for or have failed ASCT: results from a phase II HOVON study.

Rituximab-PECC induction followed by 90 Y-ibritumomab tiuxetan consolidation in relapsed or refractory DLBCL patients who are ineligible for or have failed ASCT: results from a phase II HOVON study.

Journal: British journal of haematology
Published: January 07, 2019

Phase I dose-escalation study of brentuximab-vedotin combined with dexamethasone, high-dose cytarabine and cisplatin, as salvage treatment in relapsed/refractory classical Hodgkin lymphoma: The HOVON/LLPC Transplant BRaVE study.

Phase I dose-escalation study of brentuximab-vedotin combined with dexamethasone, high-dose cytarabine and cisplatin, as salvage treatment in relapsed/refractory classical Hodgkin lymphoma: The HOVON/LLPC Transplant BRaVE study.

Journal: Haematologica
Published: November 02, 2018

Mutational Evolution in Relapsed Diffuse Large B-Cell Lymphoma.

Mutational Evolution in Relapsed Diffuse Large B-Cell Lymphoma.

Journal: Cancers
Published: October 05, 2018

Overall and disease-specific survival of Hodgkin lymphoma survivors who subsequently developed gastrointestinal cancer.

Overall and disease-specific survival of Hodgkin lymphoma survivors who subsequently developed gastrointestinal cancer.

Journal: Cancer medicine
Published: July 04, 2018

ESMO Consensus Conference on malignant lymphoma: management of 'ultra-high-risk' patients.

ESMO Consensus Conference on malignant lymphoma: management of 'ultra-high-risk' patients.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: June 21, 2018

Treatment of sporadic Burkitt lymphoma in adults, a retrospective comparison of four treatment regimens.

Treatment of sporadic Burkitt lymphoma in adults, a retrospective comparison of four treatment regimens.

Journal: Annals of hematology
Published: June 26, 2017
Showing 1-12 of 39

Last Updated: 09/26/2026